Mattia Rediti
- Oncology top 10%
- Cancer Research
- Pulmonary and Respiratory Medicine
- Radiology, Nuclear Medicine and Imaging
- Molecular Biology
- Co-authors
- Christos SotiriouVéronique DebienEvandro de AzambujaDanai FimereliMartine PiccartPhilippe AftimosElisa AgostinettoMarco Brugia
- Topics
- Cancer Immunotherapy and Biomarkers (5 papers)HER2/EGFR in Cancer Research (4 papers)Cancer Genomics and Diagnostics (4 papers)
- Partner nations
- BelgiumItalyUnited Kingdom
In The Last Decade
Mattia Rediti
15 papers receiving 345 citations
Peers
Comparison fields: 5 of 37
- Oncology 266
- Cancer Research 158
- Pulmonary and Respiratory Medicine 148
- Radiology, Nuclear Medicine and Imaging 84
- Molecular Biology 78
Countries citing papers authored by Mattia Rediti
This map shows the geographic impact of Mattia Rediti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mattia Rediti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mattia Rediti more than expected).
Fields of papers citing papers by Mattia Rediti
This network shows the impact of papers produced by Mattia Rediti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mattia Rediti. The network helps show where Mattia Rediti may publish in the future.
Co-authorship network of co-authors of Mattia Rediti
This figure shows the co-authorship network connecting the top 25 collaborators of Mattia Rediti. A scholar is included among the top collaborators of Mattia Rediti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mattia Rediti. Mattia Rediti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 3 | |
| 3 | 7 | |
| 4 | 33 | |
| 5 | 1 | |
| 6 | 15 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 0 | |
| 10 | 168 | |
| 11 | 55 | |
| 12 | 4 | |
| 13 | 3 | |
| 14 | Complete pathological response in advanced extra-gastrointestinal stromal tumor after imatinib mesylate therapy: a case report. | 6 |
| 15 | 5 | |
| 16 | 39 |
About Mattia Rediti
Mattia Rediti is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 347 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Cancer Research (158 citations), Oncology (266 citations) and Pulmonary and Respiratory Medicine (148 citations). Mattia Rediti has collaborated with scholars based in Belgium, Italy and United Kingdom. Frequent co-authors include Christos Sotiriou, Véronique Debien, Evandro de Azambuja, Danai Fimereli, Martine Piccart, Philippe Aftimos, Elisa Agostinetto, Marco Brugia, David Venet and Françoise Rothé. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.